Six Precision Medicine Companies Making Their Mark in 2020
U.S. FDA revokes emergency use status of drug touted by Trump for COVID-19
Chinese Scientist, Escorted Out Of Canadian Biolab, Sent Deadly Viruses To Wuhan
Is The Pandemic Over & A "V-Shaped" Recovery Baked-In?
FDA Withdraws Emergency Authorization For Hydroxychloroquine After HHS Official Makes Request
Combating COVID-19: How Should Banking Supervisors Respond?
Eli Lilly launches PhIII JAK study, aiming for the first drug to lower mortality in Covid-19
Dr Reddy’s Labs Signs Licensing Agreement For Gilead’s Remdesivir
Will Clinical Trials Make a House Call?
COVID-19 Drives ESG Demand
Coronavirus shows how ageism is harmful to health of older adults
Weekly Market Review: Stocks Ride Roller Coaster
Florida Reports Another Record Jump In New Cases As Global COVID-19 Count Nears 8 Million: Live Updates
Coronavirus pharma news roundup – 12/06/20
The unprecedented challenge of pricing a coronavirus vaccine
3 “Strong Buy” Penny Stocks With Massive Upside Ahead
Regeneron Starts Human Clinical Trials Of Covid-19 Antibody Cocktail
Coronavirus: why we're investigating the long-term impact on hearing
Lilly CSO: COVID-19 Antibody Treatment Could Be Ready by Fall 2020
Coronavirus has forced us to embrace digital healthcare – it could transform how we look after patients
Top Analyst Sees More Than One Path to COVID-19 Solutions for Sorrento
Celltrion trials infliximab biosimilar in recovering COVID-19 patients
COVID-19 hastens Northern Ireland push for digital health record
Did Italy's COVID-Crisis Response Show That Age-Discrimination Is Acceptable?
Lilly COVID-19 treatment could be authorized for use as soon as September
Strengthening Africa’s clinical trial capacity through an online platform
States are making it harder to sue nursing homes over COVID-19: Why immunity from lawsuits is a problem
What Would a Merger Mean for Gilead? Top Analyst Weighs In
AstraZeneca wins fresh U.S. funding in race for COVID-19 treatment
A drug for the treatment of COVID-19 complications is registered in Russia